LeMaitre Vascular was founded in 1983 and is headquartered in Burlington, US
LeMaitre Vascular Office Locations
LeMaitre Vascular has offices in Burlington, Inzell, Chiyoda, Mississauga and in 4 other locations
Burlington, US (HQ)
63 Second Ave
North Melbourne, AU
36 Munster Terrace
San Giuliano Milanese, IT
86 Viale Leone Tolstoj
Madrid, ES
Plaza De España
Mississauga, CA
608 5915 Airport Rd
Inzell, DE
Otto Volger Str. 5 A/B 65843 Sulzbach/Ts
LeMaitre Vascular Data and Metrics
LeMaitre Vascular Financial Metrics
LeMaitre Vascular's revenue was reported to be $89.2 m in 2016
Numbers are in $, USD
Revenue (Y, 2016) | 89.2 m |
Revenue growth (Y, 2015 - Y, 2016), % | 14% |
Gross profit (Y, 2016) | 62.9 m |
Gross profit margin (Y, 2016), % | 71% |
Net income (Y, 2016) | 10.6 m |
EBIT (Y, 2016) | 16.3 m |
Market capitalization (23-May-2017) | 559.4 m |
Closing share price (23-May-2017) | 29.5 |
Cash (31-Dec-2016) | 24.3 m |
LeMaitre Vascular's current market capitalization is $559.4 m.
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | Y, 2016 |
|---|---|---|---|---|
Revenue | 64.5 m | 71.1 m | 78.4 m | 89.2 m |
Revenue growth, % | 10% | 10% | 14% | |
Cost of goods sold | 19.4 m | 22.7 m | 24.2 m | 26.2 m |
Gross profit | 45.1 m | 48.4 m | 54.2 m | 62.9 m |
Gross profit Margin, % | 70% | 68% | 69% | 71% |
Operating expense total | 40.6 m | 42.1 m | 42.7 m | 46.6 m |
EBIT | 4.5 m | 6.3 m | 11.5 m | 16.3 m |
EBIT margin, % | 7% | 9% | 15% | 18% |
Interest expense | 12 k | 5 k | 5 k | 14 k |
Interest income | 4 k | 1 k | 13 k | 81 k |
Pre tax profit | 4.3 m | 6.3 m | 11.4 m | 16.2 m |
Income tax expense | 1.1 m | 2.4 m | 3.7 m | 5.7 m |
Net Income | 3.2 m | 3.9 m | 7.8 m | 10.6 m |
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 14.7 m | 18.7 m | 27.5 m | 24.3 m |
Accounts Receivable | ||||
Inventories | 3.2 m | 2.4 m | 3.6 m | 2 m |
Current Assets | 41.7 m | 48.6 m | 58.2 m | 59 m |
PP&E | 5.8 m | 6.9 m | 7 m | 8 m |
Goodwill | 15 m | 17.3 m | 17.8 m | 23.4 m |
Total Assets | 70.5 m | 81.5 m | 90.7 m | 101.9 m |
Accounts Payable | 1.2 m | 1.1 m | 1.4 m | 1.2 m |
Current Liabilities | 10.2 m | 10 m | 10.4 m | 10.5 m |
Additional Paid-in Capital | 65.4 m | 75.4 m | 82.1 m | 85.4 m |
Retained Earnings | (667 k) | 3.2 m | 8.2 m | 15.3 m |
Total Equity | 56.6 m | 68.2 m | 77.9 m | 87.5 m |
Financial Leverage | 1.2 x | 1.2 x | 1.2 x | 1.2 x |
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 3.2 m | 3.9 m | 7.8 m | 10.6 m |
Depreciation and Amortization | 2.8 m | 3.3 m | 3.4 m | 3.6 m |
Accounts Receivable | (1.2 m) | (654 k) | (1.9 m) | (922 k) |
Inventories | (2.2 m) | (2.7 m) | 608 k | |
Accounts Payable | 861 k | (1.1 m) | 2.6 m | (103 k) |
Cash From Operating Activities | 5.4 m | 5.5 m | 11.4 m | 16.9 m |
Purchases of PP&E | (2.7 m) | (1.2 m) | (2.3 m) | (2.8 m) |
Cash From Investing Activities | (6.2 m) | (7.7 m) | (3.5 m) | (17.2 m) |
Long-term Borrowings | (1.1 m) | (1.1 m) | (1.1 m) | |
Cash From Financing Activities | (961 k) | 6.7 m | 1.1 m | (2.6 m) |
| Y, 2016 | |
|---|---|
Financial Leverage | 1.2 x |
